We have shown that the upregulation of death receptors by chemotherapeutic drugs, irradiation and chemopreventive agents enhance or sensitize cancer cells to TRAIL treatment [1], [14], [15], [29], [32], [58], [59], [60], [61], [62], [63]. This evidence concerns the gene TNFSF10 and cancer.